» Articles » PMID: 11018608

Effectiveness of Nifedipine and Deflazacort in the Management of Distal Ureter Stones

Overview
Journal Urology
Specialty Urology
Date 2000 Oct 6
PMID 11018608
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate the effectiveness of medical therapy during watchful waiting in patients with distal ureter stones.

Methods: Ninety-six patients with radiopaque stones located in the distal tract of the ureter and with stone sizes of 1 cm or smaller were involved in the study. The patients were randomly divided into two groups. Group A (n = 48) received oral treatment with 30 mg of deflazacort daily (maximum 10 days) plus 30 mg of slow-release nifedipine daily (maximum 4 weeks). Group B (n = 48) underwent a wait-and-watch approach. Both groups of patients were allowed to use diclofenac on demand. Statistical analyses were carried out using Student's t test, the chi-square test, and Fisher's exact test.

Results: The average stone size was 5.8 +/- 1.8 mm for group A and 5. 5 +/- 1.4 mm for group B. No statistically significant difference was found in stone size. Stone expulsion was observed in 38 (79%) of 48 patients in group A and in 17 (35%) of 48 patients in group B. The average expulsion time was 7 days (range 2 to 10) for group A and 20 days (range 10 to 28) for group B. A statistically significant difference was observed in both the expulsion rate and the expulsion time (P <0.05). The mean amount of sodium diclofenac used was 15 mg per patient for group A and 105 mg per patient for group B (P <0.05).

Conclusions: The medical treatment proved to be effective and safe, as demonstrated by the increased stone expulsion rate, decreased expulsion time, and reduced need for analgesic therapy.

Citing Articles

Effect of a Single Dose of Deflazacort on Postoperative Pain, Swelling, and Trismus after Impacted Lower Third Molar Surgery: Randomised Clinical Trial.

Kaplan V, Cigerim L, Feslihan E, Cinarsoy Cigerim S Medicina (Kaunas). 2024; 60(8.

PMID: 39202488 PMC: 11356159. DOI: 10.3390/medicina60081206.


A Comparison Between Silodosin and Tamsulosin for Medical Expulsive Therapy of Distal Ureteric Calculus.

Abdullah A, Gupta Y, Selvaraj S, Ganapathy R, Ilangovan A, Sivalingam S Cureus. 2023; 15(10):e47008.

PMID: 37841986 PMC: 10576195. DOI: 10.7759/cureus.47008.


Efficacy of a Multicomponent Nutraceutical Formulation for the Prevention and Treatment of Urinary Tract Stones.

Maisto M, Schiano E, Luccheo G, Luccheo L, Alfieri E, Piccolo V Int J Mol Sci. 2023; 24(9).

PMID: 37176022 PMC: 10178978. DOI: 10.3390/ijms24098316.


The regular use of calcium channel blockers before flexible URS appears to facilitate primary UAS insertion: a retrospective study in a single center.

Xiang Y, Yan T, Fu M, Quan K, Shu J, Wang R Int Urol Nephrol. 2022; 55(3):547-551.

PMID: 36450869 DOI: 10.1007/s11255-022-03426-8.


Alpha-blockers as medical expulsive therapy for ureteral stones.

Campschroer T, Zhu X, Vernooij R, Lock M Cochrane Database Syst Rev. 2018; 4:CD008509.

PMID: 29620795 PMC: 6494465. DOI: 10.1002/14651858.CD008509.pub3.